Viewing nowNeodapa Tablet 10 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Gc Pharma Co., Ltd.

MFDS item code 202202299 · Approved 2022.05.31 · Insurance code 643606460
Improvement of blood glucose control in type 2 diabetes mellitus; suppression of worsening chronic heart failure and chronic kidney disease
This medicine is used in conjunction with meal or exercise therapy to help manage blood sugar levels in patients with type 2 diabetes. Additionally, in patients with chronic heart failure, it reduces the risk of death and hospitalization due to cardiovascular disease, improving quality of life. It is also effective in lowering the risk of decline in kidney function and associated mortality in patients with chronic kidney disease. It is used in combination with standard treatment for each condition and helps improve the overall health of the patient. Therefore, it is beneficial for patients with type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the initial recommended dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine is not recommended for the purpose of improving glycemic control. - eGFR less than 25 mL/min/1.73m2: Initiation of treatment with this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medicine should not be used in patients who are allergic to the active ingredient or excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with genetically related lactose intolerance or related diseases should not use this medicine due to the presence of anhydrous lactose. Patients undergoing dialysis should also not use this medicine. Caution should be exercised when administering this medicine to patients with low fluid volume or impaired kidney function. This medicine can lower blood pressure and may affect kidney function, so fluid status and kidney function must be checked before administration. Particularly in elderly patients or those taking diuretics, there is a higher risk of hypotension or reduced blood volume, so care is needed. Patients with severely impaired kidney function may have decreased blood sugar regulating effects, and administration is not recommended. Taking this medicine may cause adverse reactions such as genital infections, urinary tract infections, hypoglycemia, dehydration, diabetic ketoacidosis, among others. Genital infections, in particular, may occur more frequently in women and in patients with a history of previous infections. The risk of hypoglycemia may be higher when taken with insulin or sulfonylurea, and dosage adjustments may be necessary. Symptoms of fluid volume depletion should be reported immediately, and the medication may need to be discontinued temporarily if necessary. This medicine can rarely cause a serious infection known as Fournier's gangrene, so if there is pain, swelling, or redness around the perineum, immediate medical attention should be sought. It is advisable not to use this medicine during pregnancy or breastfeeding. Elderly patients should have their kidney function monitored more frequently and should be alert to the risk of hypotension or fluid volume depletion. This medicine may interact with insulin, sulfonylureas, diuretics, etc., so adjustments with other medications being taken may be necessary. In case of overdose, there is no specific antidote, so treatment should be provided according to symptoms, and measures should be taken as directed by a physician if needed. When driving or operating machinery, caution should be exercised considering the risk of hypoglycemia. This medicine should be kept out of the reach of children and stored in its original container.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
Yellow, biconvex, diamond-shaped film-coated tablet
PTP) 28 tablets/box (28 tablets (7 tablets/PTP x 4)), bottle) 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Gc Pharma Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.